Literature DB >> 4815082

Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.

G Boden, N Essa, O E Owen, F A Reichle.   

Abstract

A new radioimmunoassay for secretin was used to investigate (a) serum secretin responses to intraduodenally infused HCl and glucose, (b) the metabolic half-life and the volume of distribution of exogenous secretin and (c) the effect of endogenously released secretin on insulin secretion in 25 anesthetized dogs. Portal and femoral venous blood samples were taken simultaneously before, during, and after intraduodenal infusion of HCl (21 meq/30 min) and glucose (131 ml/30 min). Control experiments were performed with intraduodenal infusion of saline. Mean portal venous immunoreactive secretin concentration of six dogs rose from 313 muU/ml before to 1,060 muU/ml 10 min after initiation of the intestinal acidification (P < 0.005). Femoral venous immunoreactive secretin concentration rose from 220 muU/ml before to 567 muU/ml 15 min after intestinal acidification (P < 0.01). Secretin concentrations remained elevated during the remainder of the infusion. In the same six dogs mean portal venous immunoreactive insulin concentration rose from 38 muU/ml before to 62 muU/ml at the end of the infusion (P < 0.05). Peripheral immunoreactive insulin, glucose, and free fatty acid concentrations, however, did not change significantly. Pancreatic exocrine function was studied in four dogs. The rise in secretin concentration was followed promptly by a highly significant increase in exocrine pancreatic flow rate and bicarbonate secretion, indicating biological activity of the circulating immunoreactive secretin. The effect of intraduodenal infusion of glucose on immunoreactive secretin concentration was studied in 12 dogs. Glucose in concentrations ranging from 2.5% to 10% had no detectable influence on portal or peripheral secretin concentration. Infusion of 50% glucose caused a slight decline in secretin concentration. The metabolic clearance rate, half-life of disappearance, and volume of distribution of exogenous secretin was studied in three dogs by the constant infusion technic. The metabolic clearance rate was 730+/-34 ml/min, volume of distribution was 17.4+/-0.8% of body weight, and the half-life of disappearance was 2.8+/-0.1 min. It could be calculated that 1.38 U/kg-h(-1) of endogenous secretin was released into the peripheral circulation during the steady state period of the HCl infusion experiments. The data indicated that immunoreactive secretin was released rapidly after intestinal acidification, continued to be secreted throughout the duration of HCl infusion, and was promptly distributed in the extracellular compartment. Furthermore, they suggested that endogenously released secretin could stimulate insulin secretion. The HCl-mediated insulinogenic effect of immunoreactive secretin, however, was too weak to influence peripheral immunoreactive insulin, glucose, and free fatty acid concentrations. The failure of intraduodenal glucose to stimulate secretin release suggests that secretin is not the insulin-stimulatory factor released from the gastrointestinal tract in response to glucose.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4815082      PMCID: PMC333105          DOI: 10.1172/JCI107657

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  An automated determination of glucose utilizing a glucose oxidase-peroxidase system.

Authors:  J B HILL; G KESSLER
Journal:  J Lab Clin Med       Date:  1961-06

2.  Anatomy of body water and electrolytes.

Authors:  I S EDELMAN; J LEIBMAN
Journal:  Am J Med       Date:  1959-08       Impact factor: 4.965

3.  Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA).

Authors:  G Boden; W Y Chey
Journal:  Endocrinology       Date:  1973-06       Impact factor: 4.736

4.  Failure of endogenous stimulation of secretin and pancreozymin release to influence serum-insulin.

Authors:  R J Mahler; H Weisberg
Journal:  Lancet       Date:  1968-03-02       Impact factor: 79.321

Review 5.  Steroid dynamics under steady-state conditions.

Authors:  D T Baird; R Horton; C Longcope; J F Tait
Journal:  Recent Prog Horm Res       Date:  1969

6.  [Direct stimulation of insulin secretion in vitro by scretion].

Authors:  E F Pfeiffer; M Telib; J Ammon; F Melani; H Ditschuneit
Journal:  Dtsch Med Wochenschr       Date:  1965-09-17       Impact factor: 0.628

7.  [Determination of the half life time of secretin].

Authors:  P Lehnert; H Stahlheber; M M Forell; F H Dost; H Fritz; M Hutzel; E Werle
Journal:  Klin Wochenschr       Date:  1969-11-15

8.  Radioimmunoassay of secretin in human serum.

Authors:  J D Young; L Lazarus; D J Chisholm; F F Atkinson
Journal:  J Nucl Med       Date:  1968-12       Impact factor: 10.057

9.  Secretory rate of gastric acid and pancreatic bicarbonate in the dog after feeding.

Authors:  S J Rune; F W Henriksen
Journal:  Gastroenterology       Date:  1967-06       Impact factor: 22.682

10.  The gastrointestinal stimulus to insulin release. II. A dual action of secretin.

Authors:  E W Kraegen; D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  19 in total

1.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Gastrin inhibition of the pyloric sphincter.

Authors:  R S Fisher; G Boden
Journal:  Am J Dig Dis       Date:  1976-06

3.  Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; Y Okabayashi; T Nakamura; M Fujii; T Oka; S Tani; S Baba
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

4.  Effects of a protein meal, intraduodenal HCl, and oleic acid on portal and peripheral venous secretin and on pancreatic bicarbonate secretion.

Authors:  G Boden; R M Wilson; N Essa-Koumar; O E Owen
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

5.  Pathophysiology of gastrin and secretin.

Authors:  K D Buchanan; J E Ardill
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

Review 6.  Radioimmunoassay of secretin. A critical review and current status.

Authors:  T M Chang; W Y Chey
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

7.  Effect of endogenous secretin on plasma glucagon after total pancreatectomy.

Authors:  T Sudo; T Suzuki; T Tobe; H Umemura; S Shiraha; T Kuyama
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

8.  Disappearance half-time of endogenous and exogenous secretin in dogs.

Authors:  P J Curtis; H R Fender; P L Rayford; J C Thompson
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

9.  Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.

Authors:  V Schusdziarra; V Harris; J M Conlon; A Arimura; R Unger
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

10.  Mannitol and glucose: effects on gastric acid secretion and endogenous gastric inhibitory polypeptide (GIP).

Authors:  T M O'Dorisio; J T Spaeth; E W Martin; K R Sirinek; N R Thomford; E L Mazzaferri; S Cataland
Journal:  Am J Dig Dis       Date:  1978-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.